Cetrorelix: Deep Dive: How It Works, Who Uses It, and Safety Profile
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
A deep dive into Cetrorelix, a GnRH antagonist used in fertility treatments to prevent premature ovulation. Learn about its mechanism, uses, and safety.
# Cetrorelix: A Deep Dive into How It Works, Who Uses It, and Its Safety Profile
Cetrorelix is a gonadotropin-releasing hormone (GnRH) antagonist that plays a critical role in assisted reproductive technology (ART). By preventing premature ovulation, it allows for the controlled maturation of eggs, increasing the chances of a successful pregnancy. This article provides a deep dive into cetrorelix, exploring its mechanism of action, its use in fertility treatments, and its safety profile.
The Science of Cetrorelix: A Direct Blockade
Cetrorelix works by directly and competitively blocking GnRH receptors in the pituitary gland. This immediate blockade prevents the secretion of luteinizing hormone (LH), the hormone that triggers ovulation. By preventing the LH surge, cetrorelix allows for the controlled stimulation of the ovaries and the retrieval of mature eggs for in vitro fertilization (IVF) [1].
A Key Tool in Fertility Treatment
Cetrorelix is primarily used in women undergoing controlled ovarian stimulation for IVF. It is administered during the stimulation phase to prevent a premature LH surge, which could lead to the release of immature eggs and the cancellation of the treatment cycle. By giving clinicians precise control over the timing of ovulation, cetrorelix helps to optimize the number and quality of eggs retrieved [2].
Dosing and Administration
Cetrorelix is administered as a subcutaneous injection. The most common protocol involves a daily injection of 0.25 mg, starting on a specific day of the stimulation cycle and continuing until the day of hCG administration, which triggers final egg maturation. A single-dose protocol of 3 mg is also available [3].
Safety Profile and Side Effects
Cetrorelix is generally well-tolerated. The most common side effects are mild and transient, and include injection site reactions, such as redness, itching, and swelling. Some women may also experience headaches or nausea. Ovarian hyperstimulation syndrome (OHSS), a potential complication of all ovarian stimulation protocols, is a more serious but less common risk [4].
| Feature | Cetrorelix | Ganirelix | Lupron (Leuprolide) |
| :--- | :--- | :--- | :--- |
| Mechanism | GnRH Antagonist | GnRH Antagonist | GnRH Agonist |
| Use in IVF | Prevent premature ovulation | Prevent premature ovulation | Prevent premature ovulation |
| Administration| Subcutaneous | Subcutaneous | Subcutaneous/Intramuscular |
| Onset of Action | Rapid | Rapid | Slow (after initial flare) |
Key Takeaways
Cetrorelix is a GnRH antagonist that prevents premature ovulation during IVF treatment.
It works by directly blocking the action of GnRH on the pituitary gland.
Cetrorelix allows for controlled ovarian stimulation and optimized egg retrieval.
The most common side effects are mild injection site reactions.
> Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy or making changes to your health regimen.
References
[1] Cetrorelix: Uses, Interactions, Mechanism of Action. https://go.drugbank.com/drugs/DB00050
[2] Cetrotide®: GnRH Antagonist for cycle control |Merck Group. https://hcp.merckgroup.com/en/fertility/portfolio/therapeutics/cetrotide.html
[3] Cetrorelix (subcutaneous route) - Side effects & dosage. https://www.mayoclinic.org/drugs-supplements/cetrorelix-subcutaneous-route/description/drg-20062654
[4] Cetrotide® 0.25 mg (cetrorelix acetate for injection). https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021197s030lbl.pdf
---